Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002064875 | SCV002407732 | benign | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2022-10-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004761844 | SCV005372429 | uncertain significance | not provided | 2023-06-13 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. |
Prevention |
RCV003967939 | SCV004783578 | likely benign | COL12A1-related disorder | 2023-03-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |